Stuttgart - Delayed Quote EUR
Aldeyra Therapeutics Inc (137.SG)
2.2340
+0.0970
+(4.54%)
As of 6:21:44 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-43,208.7470
-43,208.7470
-30,326.1280
-56,637.1870
-42,555.9070
Investing Cash Flow
-44,915.7550
-44,915.7550
30,000
-29,954.5300
-7.8060
Financing Cash Flow
-171.4220
-171.4220
-1,270.2200
1,220.0920
194,496.3910
End Cash Position
54,527.0920
54,527.0920
142,823.0160
144,419.3640
229,790.9890
Interest Paid Supplemental Data
1,753.7920
1,753.7920
1,702.1880
1,338.5420
1,337.0830
Capital Expenditure
-9.5290
--
--
-16.3170
-7.8060
Issuance of Capital Stock
--
--
--
--
189,811.6110
Repayment of Debt
-292.5000
-292.5000
-1,042.5000
--
--
Free Cash Flow
-43,208.7470
-43,208.7470
-30,326.1280
-56,653.5040
-42,563.7130
12/31/2021 - 9/14/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MSCL.TO Satellos Bioscience Inc.
0.6900
+11.29%
RVX.TO Resverlogix Corp.
0.0400
+14.29%
IMNN Imunon, Inc.
0.8766
-2.38%
PALI Palisade Bio, Inc.
0.7012
-0.88%
CRIS Curis, Inc.
1.5400
+2.67%
JAGX Jaguar Health, Inc.
8.27
+24.76%
DOMH Dominari Holdings Inc.
4.4750
-1.21%
ALNY Alnylam Pharmaceuticals, Inc.
239.83
-0.88%
VXRT Vaxart, Inc.
0.3572
+3.94%
BHVN Biohaven Ltd.
22.68
+5.88%